Clinical Trial Update: Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial WATCH-TMVR is evaluating the Watchman left atrial appendage occlusion device in patients with nonvalvular atrial fibrilla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Mitral Regurgitation
• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Watchman

Snippet

Sponsor: Mayo Clinic | Conditions: Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation | NA | Status: RECRUITING